In the public interest, ministers need the advice they receive on matters relating to the regulation of medicines and medical devices to be impartial. They also need to be able to seek such advice from a wide range of highly skilled professionals who are senior and well regarded in their respective fields and from a range of appointed lay and patient representatives.
A number of independent advisory committees have been established to provide such an advice. These committees can also establish working group to address specific problems. Members of these committees receive no remuneration but are paid expenses. This section sets out details about the terms of references of these various committees, their members and the work they undertake.
Latest committee documents
12 Jan 2012
|
Commission on Human Medicines minutes - 8 December 2011
(55Kb)
06 Dec 2011
|
Chemistry, Pharmacy and Standards Expert Advisory Group summary minutes - 6 December 2011
(28Kb)
30 Nov 2011
|
Clinical Trials Expert Advisory Group summary minutes - 30 November 2011
(38Kb)
27 Nov 2011
|
Cardiovascular, Diabetes, Renal, Respiratory and Allergy Expert Advisory Group summary minutes - 13 September 2011
(39Kb)
09 Nov 2011
|
Pharmacovigilance Expert Advisory Group summary minutes - 9 November 2011
(29Kb)
08 Nov 2011
|
Chemistry, Pharmacy and Standards Expert Advisory Group summary minutes - 8 November 2011
(29Kb)
03 Nov 2011
|
Committee on the Safety of Devices Meeting - 3 November 2011
(86Kb)
02 Nov 2011
|
Clinical Trials Expert Advisory Group summary minutes - 2 November 2011
(28Kb)
Medicines advisory bodies
The medicines advisory bodies were introduced under the Medicines Act 1968. They provide advice to ministers (who are the Licensing Authority) on aspects of medicines regulation.
Devices
Independent Scientific Advisory Committee for MHRA database research
Go to the section on the Independent Scientific Advisory Committee for MHRA database research

